Home
>
National Drug Code (NDC)
>
BEXXAR
BEXXAR - 0007-3260-31 - (tositumomab)
Drug Information of BEXXAR
| Product NDC: | 0007-3260 |
| Proprietary Name: | BEXXAR |
| Non Proprietary Name: | tositumomab |
| Active Ingredient(s): | & nbsp; tositumomab |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BEXXAR
| Product NDC: | 0007-3260 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125011 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090715 |
Package Information of BEXXAR
| Package NDC: | 0007-3260-31 |
| Package Description: | 1 KIT in 1 PACKAGE, COMBINATION (0007-3260-31) * 16.1 mL in 1 VIAL, SINGLE-USE * 2.5 mL in 1 VIAL, SINGLE-USE |
NDC Information of BEXXAR
| NDC Code | 0007-3260-31 |
| Proprietary Name | BEXXAR |
| Package Description | 1 KIT in 1 PACKAGE, COMBINATION (0007-3260-31) * 16.1 mL in 1 VIAL, SINGLE-USE * 2.5 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 0007-3260 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tositumomab |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20090715 |
| Marketing Category Name | BLA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
